Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.

MLA

Freet, Christopher S., et al. “Ecological Momentary Assessment and Cue-Elicited Drug Craving as Primary Endpoints: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Testing the Efficacy of a GLP-1 Receptor Agonist in Opioid Use Disorder.” Addiction Science & Clinical Practice, vol. 19, no. 1, July 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13722-024-00481-7.

APA

Freet, C. S., Evans, B., Brick, T. R., Deneke, E., Wasserman, E. J., Ballard, S. M., Stankoski, D. M., Kong, L., Raja-Khan, N., Nyland, J. E., Arnold, A. C., Krishnamurthy, V. B., Fernandez-Mendoza, J., Cleveland, H. H., Scioli, A. D., Molchanow, A., Messner, A. E., Ayaz, H., Grigson, P. S., & Bunce, S. C. (2024). Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder. Addiction Science & Clinical Practice, 19(1), 1–13. https://doi.org/10.1186/s13722-024-00481-7

Chicago

Freet, Christopher S., Brianna Evans, Timothy R. Brick, Erin Deneke, Emily J. Wasserman, Sarah M. Ballard, Dean M. Stankoski, et al. 2024. “Ecological Momentary Assessment and Cue-Elicited Drug Craving as Primary Endpoints: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Testing the Efficacy of a GLP-1 Receptor Agonist in Opioid Use Disorder.” Addiction Science & Clinical Practice 19 (1): 1–13. doi:10.1186/s13722-024-00481-7.